NEW YORK (Reuters Health) - Men who opt for hormone-blocking therapy to treat prostate cancer may be increasing their risk of developing colon cancer, hints a study published this week in the Journal ...
In total, 214 GPs participated (response rate, 69%). The overall experience with providing survivorship care was 7.0 ± 1.6 for prostate cancer and 6.4 ± 1.8 for colon cancer. Lowest scores were seen ...
TYLER, Texas (KLTV) - June is Men’s Health month, a time to prioritize prevention. Infectious disease specialist Dr. Ed Dominguez stressed the importance of screening for prostate and colon cancer.